Treatment of delirium in the context of anti-N-methyl-D-aspartate receptor antibody encephalitis

J Am Acad Child Adolesc Psychiatry. 2015 Mar;54(3):233-4. doi: 10.1016/j.jaac.2014.12.014.

Authors

Alexander M Scharko¹, Jessica Panzer², Chelsey M McIntyre³

Affiliations

¹ The Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia. Electronic address: scharkoa@email.chop.edu.
² The Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
³ The Children's Hospital of Philadelphia, Philadelphia.

PMID: 25721189
DOI: 10.1016/j.jaac.2014.12.014

No abstract available

Publication types

Case Reports
Letter
Review

MeSH terms

Adolescent
Animals
Anti-N-Methyl-D-Aspartate Receptor Encephalitis / drug therapy
Anti-N-Methyl-D-Aspartate Receptor Encephalitis / psychology*
Antipsychotic Agents / therapeutic use
Autoantibodies / cerebrospinal fluid*
Benzodiazepines / therapeutic use*
Cerebrospinal Fluid
Delirium / drug therapy*
Female
Humans
Length of Stay
Olanzapine
Patient Transfer
Receptors, N-Methyl-D-Aspartate / immunology*

Substances

Antipsychotic Agents
Autoantibodies
Receptors, N-Methyl-D-Aspartate
Benzodiazepines
Olanzapine